Live feed07:30:16·897dSECFilingvia QuantisnowVirpax Pharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.VRPX· Virpax Pharmaceuticals Inc.Health CareOriginal source
